Entera Bio Ltd (ENTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,915 | 9,056 | 9,189 | 11,019 | 7,585 |
| Receivables | 42 | 57 | N/A | N/A | N/A |
| Other current assets | 383 | 482 | 562 | 238 | 431 |
| TOTAL | $7,340 | $9,595 | $9,751 | $11,257 | $8,016 |
| Non-Current Assets | |||||
| PPE Net | 65 | 76 | 87 | 100 | 108 |
| Other Non-Current Assets | 336 | 364 | 401 | 408 | 441 |
| TOTAL | $401 | $440 | $488 | $508 | $549 |
| Total Assets | $7,741 | $10,035 | $10,239 | $11,765 | $8,565 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 184 | 69 | 66 | 83 | 1,896 |
| Accrued Expenses | 765 | 1,070 | 902 | 874 | N/A |
| TOTAL | $1,111 | $1,294 | $1,121 | $1,091 | $2,027 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 178 | 209 | 255 | 288 | 302 |
| TOTAL | $178 | $209 | $255 | $288 | $302 |
| Total Liabilities | $1,289 | $1,503 | $1,376 | $1,379 | $2,329 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,832 | 36,325 | 35,785 | 35,481 | 28,814 |
| Common Shares | 1 | 1 | 1 | 1 | N/A |
| Retained earnings | -111,569 | -108,548 | -106,403 | -104,386 | -102,391 |
| Other shareholders' equity | 41 | 41 | 41 | 41 | 41 |
| TOTAL | $6,452 | $8,532 | $8,863 | $10,386 | $6,236 |
| Total Liabilities And Equity | $7,741 | $10,035 | $10,239 | $11,765 | $8,565 |